Proprietary Nasax® Platform Enables Superior Drug Delivery

Greater intranasal absorption area enables faster delivery and higher maximal drug concentration than liquid formulations

The powder

Nasax® – proprietary powder formulation for intranasal delivery comprised of uniform spherical API and a carrier approved for inhalation. Technology aims for a rapid and precise delivery of the drug to the bloodstream and brain. Stability data demonstrated potential for longer shelf life.

Small unified API’s particles ensure stable and repeatable absorption of drug.

Large Lactose particles serve as de-agglomerators and carriers for the powder into the nose.

Group 50
Nasax proprietary powder
Group 49